EXAS - Exact Sciences Corporation

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by T0rm3nted, Jun 15, 2016.

  1. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,447
    Likes Received:
    3,268
    [​IMG]
    Exact Sciences Corporation (EXAS) is a molecular diagnostics company focused on the early detection and prevention of some forms of cancer. The Company's product pipeline includes Lung Cancer Nodules, Pancreatic Cancer Screening, Esophageal Cancer Screening, Lung Cancer Pipeline, Pancreatic Cancer Pipeline and Esophageal Cancer Pipeline. It has developed a non invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a non invasive stool based deoxyribonucleic acid (DNA) screening test designed to detect DNA markers. In addition to DNA markers, its test includes a protein marker to detect blood in the stool, utilizing an antibody based fecal immunochemical test. The United States Food and Drug Administration (FDA) approved Cologuard for use as sDNA non-invasive colorectal cancer screening test. Cologuard is available through healthcare providers. It also focused on developing its pipeline for future products and services.
     
  2. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,447
    Likes Received:
    3,268
  3. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Another +11% pop!
     
  4. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Exact Sciences Stock Rebounds On Leaked Testing Guidelines

    Cancer diagnostics company Exact Sciences (EXAS) was up 16% in premarket trading Wednesday after leaping 33% Tuesday afternoon, apparently because of a leaked journal article recommending use of its colon-cancer test.

    Exact Sciences launched its Cologuard DNA screening test for colon cancer in August 2014, but it’s struggled with reimbursement from government agencies. Its stock plunged 46% on Oct. 6 after the U.S. Preventive Services Task Force (USPSTF) issued its report grading colon-cancer screening tests and recommended Cologuard only as an “alternative” test to colonoscopy. The stock had traded below 10 almost continually since then.

    However, early Tuesday afternoon shares spiked from around 7 to above 9, leaving both the company and Wall Street scratching their heads.
     
  5. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,447
    Likes Received:
    3,268
    Reported before open today (7/26/16)
    Earnings: EPS -$0.46 Revenue $21.2M
    Estimates: EPS -$0.55 Revenue $18.54M

    Up 30.10% today
     
  6. Stockaholic

    Stockaholic Content Manager

    Joined:
    Mar 29, 2016
    Messages:
    13,767
    Likes Received:
    7,050
    Exact Sciences reports 3Q loss
    MADISON, Wis. (AP) _ Exact Sciences Corp. (EXAS) on Wednesday reported a loss of $37.8 million in its third quarter.

    The Madison, Wisconsin-based company said it had a loss of 36 cents per share.

    The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 43 cents per share.

    The molecular diagnostics company posted revenue of $28.1 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $24.9 million.

    Exact Sciences expects full-year revenue in the range of $93 million to $95 million.

    Exact Sciences shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.
     
  7. Tiptopptrader

    Tiptopptrader Well-Known Member

    Joined:
    Mar 31, 2016
    Messages:
    4,895
    Likes Received:
    1,124
    Not a good market day to miss

    upload_2016-10-26_7-8-48.png
     
  8. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,447
    Likes Received:
    3,268
    Analyst Upgrade/Downgrade Update

    Brokerage firm: The Benchmark Company
    Change: Coverage Reiterated/Price Target Changed
    Previous Rating: N/A
    Current Rating: Hold
    Previous Price Target: $14
    Current Price Target: $17
     
  9. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,447
    Likes Received:
    3,268
    Recent Insider Trading:

    Multiple insiders making large sales of ~50% of their positions

    upload_2016-11-16_1-44-59.png
    upload_2016-11-16_1-45-11.png
     
  10. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Good morning EXAS longs!

    Congrats! :D
     
  11. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    MADISON, Wis., April 27, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that the company generated revenues of $48.4 million and completed approximately 100,000 Cologuard tests during the quarter ended March 31, 2017. First-quarter 2017 revenues and completed Cologuard test volume grew 226 percent and 150 percent from the same period of 2016, respectively.
     
  12. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    EXAS going to have a nice move today!
     
  13. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Looking good still!
     
  14. fireopal

    fireopal Well-Known Member

    Joined:
    Apr 18, 2016
    Messages:
    2,278
    Likes Received:
    517
  15. fireopal

    fireopal Well-Known Member

    Joined:
    Apr 18, 2016
    Messages:
    2,278
    Likes Received:
    517
  16. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Good bounce off $40!
     
  17. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Looks like that $100 support was good for a bounce
     
  18. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    9,524
    Likes Received:
    3,526
    Well look at that!
     

Share This Page